Compound Heterozygosity for MSH6 Mutations in a Pediatric Lymphoma Patient
Journal of Pediatric Hematology/Oncology, 2009An 8-year-old male with lymphoblastic lymphoma was noted to have multiple café-au-lait macules and possible Lisch nodules. Work-up revealed the child as compound heterozygous for mutations in the DNA mismatch repair gene, MSH6. This case emphasizes many clinical issues regarding individuals with biallelic mismatch repair mutations, a rare and easily ...
Antoinette, Peters +4 more
openaire +2 more sources
Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia
Neurobiology of Aging, 2011Intronic MAPT mutations altering exon 10 splicing lead mainly to an increase of 4Rtau. The objective of this study is to report clinical, genetic, and neuropathological data of an apparently sporadic early onset frontotemporal dementia (FTD) case associated with 2 novel intronic MAPT gene mutations IVS10+4A > C and IVS9-15T > C that increase 3Rtau ...
Maria, Anfossi +18 more
openaire +2 more sources
Compound Heterozygosity for Hb E-Saskatoon and β-Thalassemia
Hemoglobin, 1991(1991). Compound Heterozygosity for Hb E-Saskatoon and β-Thalassemia. Hemoglobin: Vol. 15, No. 4, pp. 345-346.
openaire +2 more sources
Compound heterozygosity in a South African patient with Facioscapulohumeral muscular dystrophy
Neuromuscular Disorders, 2012Facioscapulohumeral muscular dystrophy (FSHD) is characterised by weakness and atrophy of the facial and shoulder girdle muscles. The FSHD phenotype segregates as an autosomal dominant trait and is caused by a deletion of an integral number of 3.3 kilobase pair (kb) repeat units on chromosome 4q35.
Antonel, Olckers +5 more
openaire +2 more sources
Hb Lepore (Pylos)/Hb S compounds heterozygosity in two Greek families
American Journal of Hematology, 1995AbstractWe have studied three compound heterozygotes for Hb Lepore (“Pylos”)/HbS hemoglobin, a combination quite uncommon in the literature. It is of interest that while two of these cases are clinically similar to those thus far reported, the third one is free of symptoms and the diagnosis was put incidentally.
E, Voskaridou +4 more
openaire +2 more sources
Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency
Biochemical and Biophysical Research Communications, 1991In a kindred with three hyperlipidemic subjects who had premature atherosclerosis and complete deficiency of hepatic lipase activity, we had previously identified a novel structural hepatic lipase gene variant. We now report the identification of three more hepatic lipase gene mutations in this family and demonstrate that compound heterozygosity for ...
R A, Hegele, J A, Little, P W, Connelly
openaire +2 more sources
Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiency
Thrombosis and Haemostasis, 2013Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiency -
Vicente Vicente +11 more
openaire +1 more source
The effect of population stratification on the frequency of compound heterozygosity
Genetica, 2011Your article is protected by copyright andall rights are held exclusively by SpringerScience+Business Media B.V.. This e-offprintis for personal use only and shall not be self-archived in electronic repositories. If youwish to self-archive your work, please use theaccepted authors version for posting to yourown website or your institutions repository.
openaire +2 more sources
Compound heterozygosity for haemoglobin S and haemoglobin E
British Journal of Haematology, 2000R, Gupta, M, Jarvis, A, Yardumian
openaire +2 more sources
Molecular evidence for compound heterozygosity in hereditary fructose intolerance.
American journal of human genetics, 1990Hereditary fructose intolerance (HFI) is an inborn error of metabolism, inherited as an autosomal recessive disorder and caused by a decrease in the activity of fructose-1-phosphate aldolase (aldolase B) in affected individuals. Investigation of the molecular basis of HFI is reported here by the identification of two molecular lesions in the aldolase B
C, Dazzo, D R, Tolan
openaire +1 more source

